Sterling Accuris Diagnostics

Sterling Accuris Diagnostics, founded in 2016, is a leading Indian pathology laboratory provider. Specializing in a wide range of blood tests and full body checkup packages, the company operates within the Medical Testing & Clinical Laboratories and Healthcare industries. It has established itself as a premier provider of accurate and reliable diagnostic services across India, committed to meeting diverse healthcare needs with advanced technology and quality assurance.

The company boasts an extensive operational network, featuring over 250 collection centers and laboratories across multiple states, enabling the performance of more than 2,000 distinct tests. These include specialized health packages for various demographics. Sterling Accuris Diagnostics emphasizes advanced technology and stringent quality control, holding NABL accreditation. Employing 1,000-5,000 employees, the organization prioritizes customer satisfaction through precise diagnostic capabilities. Meet Sterling Accuris Diagnostics's team to learn about the professionals behind their services.

Serving hospitals, corporate clients, and individuals, Sterling Accuris Diagnostics demonstrates a versatile market approach. The company received $34 million in funding from Morgan Stanley Private Equity Asia in September 2021. With a revenue of $211.3M, Sterling Accuris Diagnostics continues to enhance its market presence and service portfolio. Their strategic focus on accuracy, advanced diagnostics, and customer-centricity solidifies their role in India's health infrastructure. Explore financial highlights for detailed fiscal performance insights.